Kimi K3 released scenario doc v1.24.0 (commit 076c174) at 1:45 PM PT with 509 checkable claims. Three new per-window cadence claims added: EX-507 (AI-credited drug candidate clinical milestones, anchored to Insilico ISM8969 FIH dosing Jun 18 and Absci ABS-201 positive interim Ph1 Jun 24), EX-508 (robotaxi new-market launches including Waymo 9+ 2026 metros, Tesla Tampa, WeRide Madrid, Baidu Switzerland), and EX-509 (humanoid commercialization with Figure BotQ 12k/yr and 1X Hayward factory). All three first windows were provisionally satisfied at creation, bringing the EX first-window satisfaction rate to 86/117 (73.5%). K3 also committed advance notes for E0-024/E0-025 (both remain OPEN) and UK AISI corroborations for EX-482/483. The expansion from 506 to 509 claims continues K3's steady forecasting growth — now averaging ~1.06 claims per day since v1.0.